Background To explore the existing evidence of the real-world implementation of patient-
reported outcomes (PROs) in oncology clinical practice and address two aims:(1) …

Purpose Patient-reported outcome measurements (PROMs) are increasingly used for
cancer patients receiving active treatment, but little is known about the implementation and …

Haematological malignancies can have devastating effects on the patients' physical,
emotional, psycho-sexual, educational and economic health. With the improvement of …

Therapeutic blockade of PD-1/PD-L1 shows promising results in Hodgkin's lymphoma (HL)
and in some diffuse large B-cell lymphoma (DLBCL) patients, but biomarkers predicting …

The aim of this study was to measure the prevalence of FCR among a sample of French
lymphoma survivors and to determine factors associated with clinical levels of FCR. The …

Some concerns have emerged about the evidence of benefits on survival outcomes or
quality of life of new anticancer drugs. In parallel, the decreased cancer mortality leads to an …

Background Previous studies have indicated that accompanying socially underserved
cancer patients through Patient Navigator (PN) or PN-derived procedures improves therapy …

Background To the authors' knowledge, there is limited information regarding the long‐term
risk of congestive heart failure (CHF) among patients with follicular lymphoma, a prevalent …

Background Previous studies have suggested that lymphoma survivors commonly display
altered Health-Related Quality of Life (HRQoL). Because these were predominantly cross …

Background: After the completion of chemotherapy, survivors of lymphoma are at risk of
developing late effects of their cancer treatment, which can negatively impact their quality of …